相关实验视频
Updated: Jul 15, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
多发性硬化症的遗传风险变体严重程度与大脑缩有关
Christiane Gasperi1, Tun Wiltgen1,2, Julian McGinnis1,2,3
1Department of Neurology, School of Medicine, Technical University of Munich, Munich, Germany.
遗传变异rs10191329与多发性硬化症 (MS) 患者的脑缩增加有关. 这一发现可能有助于在临床试验中对患者进行分层,以获得更好的结果.
科学领域:
- 神经免疫学 神经免疫学
- 遗传学 是一个遗传学.
- 神经成像是一种神经成像.
背景情况:
- DYSF-ZNF638位点内含一种遗传变异,rs10191329,此前与多发性硬化症 (MS) 长期不良临床结果有关.
- 了解遗传因素对MS疾病进展的影响对于开发向疗法至关重要.
研究的目的:
- 调查rs10191329遗传变体与复发性多发性硬化症患者的大脑缩之间的关联.
- 确定rs10191329是否可以作为MS疾病进展的生物标志物.
主要方法:
- 磁共振成像 (MRI) 用于测量大脑缩.
- 分析了748名多发性硬化患者的发现队列和360名多发性硬化患者的复制队列.
- 进行了统计分析,以评估rs10191329小等位基因 (A) 与大脑缩率之间的关联.
主要成果:
- 观察到rs10191329*A等位基因与增加的大脑缩之间存在显著的关联.
- 携带rs10191329*A等位基因的患者大约有28%的脑缩.
- 这些发现在发现和复制队伍中都是一致的.
结论:
- rs10191329遗传变异与复发性多发性硬化症中的加速脑缩有关.
- 基于rs10191329状态的患者分层可能有利于MS的临床试验.
- 对这种关联背后的机制进行进一步的研究可能会揭示MS的新型治疗点.
更多相关视频
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
相关概念视频
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...